AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it was spun off from the device maker Abbott Laboratories in 2013, will step down in July.

Feb 20 (Reuters) - AbbVie (ABBV.N), opens new tab on Tuesday said Chief Operating Officer Robert Michael would succeed Richard Gonzalez to become the second-ever CEO of the drugmaker on July 1.

AbbVie announced longtime CEO Richard Gonzalez will step down and be succeeded by president and chief operating officer Robert Michael. The pharma giant announced Tuesday morning that Gonzalez will ...

AbbVie Inc.’s Chief Executive Officer Richard A. Gonzalez will retire after a colorful tenure that included the multibillion takeover of Botox-maker Allergan as he raced to wean the company off ...

AbbVie Inc.’s founding CEO Richard Gonzalez will step down July 1, the drugmaker said Tuesday, and will be replaced by the company’s current president and chief operating officer, Robert Michael.

AbbVie’s other top execs cashed in last year, as well. Incoming CEO Michael saw his total compensation increase from $9.8 million to $14.4 million, with most of the bump coming from his change ...

AbbVie's CEO Richard Gonzalez wanted one thing and one thing only for Christmas: Cerevel Therapeutics wrapped up quickly and neatly under his Christmas tree. After months of negotiations ...

As longtime AbbVie CEO Rick Gonzalez drives the company through its much-dreaded year of Humira biosimilar erosion, his eventual exit is coming into view. In his 10 years at the helm, the CEO has ...

Former AbbVie CEO Richard Gonzalez sold his Hidden Hills home for $21.7 million in the pharma executive’s latest real estate move this year. The closing had been expected after the six-bed ...

AbbVie said longtime executive Robert Michael will become the company's new CEO, replacing Richard Gonzalez. Michael, who is AbbVie's president and chief operating officer, will become the ...